UPDATED Apr 26, 2024
Potentially undervalued companies with a strong past performance and robust balance sheet.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
NOVO B | kr.886.60 | 2.4% | 57.7% | kr.4.0t | kr.904.20 | PE47.3x | E14.7% | 1.1% | ||
NOVN | CHF89.50 | 4.6% | -1.8% | CHF182.6b | CHF99.16 | PE21.9x | E10.0% | 3.7% | ||
ROG | CHF221.00 | -0.5% | -21.2% | CHF178.2b | CHF279.39 | PE15.3x | E8.6% | 4.3% | ||
VRTX | US$397.48 | 0.8% | 16.7% | US$102.7b | US$459.72 | PE28.4x | E11.5% | n/a | ||
CSL | AU$273.30 | 1.4% | -9.1% | AU$132.1b | AU$306.71 | PE34.9x | E14.7% | 1.3% | ||
BMRN | US$80.91 | -8.7% | -15.8% | US$15.4b | US$109.96 | PE74.7x | E29.6% | n/a | ||
INCY | US$51.68 | -1.3% | -30.5% | US$11.6b | US$75.20 | PE19.4x | E18.8% | n/a | ||
300122 | CN¥34.83 | -14.0% | -35.8% | CN¥83.4b | CN¥62.47 | PE11.1x | E23.8% | 2.3% | ||
300896 | CN¥297.01 | 6.3% | -45.4% | CN¥63.9b | CN¥442.31 | PE32.4x | E25.1% | 1.6% | ||
ORNBV | €35.85 | 10.6% | -15.9% | €5.0b | €39.20 | PE23.2x | E11.2% | 4.5% | ||
9926 | HK$48.70 | 10.9% | 13.7% | HK$42.2b | HK$59.95 | PE19.2x | E12.0% | n/a | ||
TECN | CHF332.60 | -0.2% | -14.2% | CHF4.3b | CHF395.57 | PE32.3x | E9.2% | 0.9% | ||
688278 | CN¥61.34 | -2.1% | 35.3% | CN¥25.0b | CN¥89.20 | PE41.6x | E30.5% | 0.7% | ||
HCM | UK£2.90 | 7.4% | 15.3% | UK£2.5b | UK£4.28 | PE30.7x | E18.7% | n/a | ||
CAMX | kr490.00 | 1.0% | 110.1% | kr28.2b | kr577.17 | PE65.4x | E50.0% | n/a | ||
CORT | US$22.80 | -0.7% | 1.2% | US$2.4b | US$42.80 | PE22.4x | E25.9% | n/a | ||
6472 | NT$752.00 | 6.5% | 33.8% | NT$76.1b | NT$865.00 | PE25.1x | E22.9% | 1.6% | ||
300009 | CN¥9.93 | 1.6% | -10.1% | CN¥16.6b | CN¥19.54 | PE18.9x | E16.7% | 2.5% | ||
NATCOPHARM | ₹1,027.90 | 2.9% | 78.8% | ₹184.1b | ₹975.36 | PE14.4x | E14.6% | 0.9% | ||
600285 | CN¥25.30 | 7.8% | 51.4% | CN¥14.3b | n/a | PE27.1x | E16.3% | 2.4% | ||
4530 | JP¥3,779.00 | 1.6% | 0.8% | JP¥286.2b | JP¥3,950.00 | PE20.5x | E12.6% | 2.2% | ||
2005 | HK$4.79 | 1.7% | -12.4% | HK$14.2b | HK$6.23 | PE10.8x | E15.0% | 3.5% | ||
301207 | CN¥21.28 | -6.1% | -34.9% | CN¥12.8b | CN¥33.20 | PE15.9x | E24.2% | 2.8% | ||
HRMY | US$29.32 | -0.3% | -9.1% | US$1.7b | US$41.50 | PE12.9x | E25.8% | n/a |